Holen Sie sich die Stockscreener-App
11.22
0.27%
0.03
Keen Vision Acquisition Corp Aktie (KVAC) Neueste Nachrichten
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PIK, SMAR, KVAC on Behalf of Shareholders - ACCESS Newswire
Medera Presented Updated Results from First-In-Human Gene - GlobeNewswire
Medera Presented Updated Results from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at 2025 HFpEF Summit - Yahoo Finance
Keen Vision Acquisition Co. (NASDAQ:KVAC) Sees Significant Growth in Short Interest - MarketBeat
KVAC stock soars to all-time high, touches $11.25 By Investing.com - Investing.com Canada
Keen Vision Acquisition Corp. Secures Funding to Extend Merger Deadline By Investing.com - Investing.com Australia
KVAC stock soars to all-time high, touches $11.25 - Investing.com
Keen Vision Acquisition Corp. Secures Funding to Extend Merger Deadline - Investing.com India
Mizuho Securities USA LLC Has $11.10 Million Position in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Keen Vision Acquisition (NASDAQ:KVAC) Trading 0.2% HigherStill a Buy? - MarketBeat
Keen Vision Acquisition (NASDAQ:KVAC) Shares Up 0.2% – What’s Next? - Defense World
KVAC stock soars to all-time high of $11.19 amid market optimism - Investing.com Australia
KVAC stock soars to all-time high of $11.19 amid market optimism By Investing.com - Investing.com South Africa
Medera Receives DSMB Clearance to Initiate Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial for SRD-001 Gene Therapy in Heart Failure with Reduced Ejection Fraction - GlobeNewswire
Medera Receives DSMB Clearance to Initiate Phase 2 Portion - GlobeNewswire
STOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerNHHS, KVAC, AMPS, AVTE - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – NHHS, KVAC, AMPS, AVTE - GlobeNewswire Inc.
Medera Completes Patient Dosing for Heart Failure Treatment - Yahoo Finance
Medera completes patient dosing in Phase 1/2a MUSIC-HFrEF - TipRanks
Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF - GlobeNewswire
Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction - Yahoo Finance
KVAC stock soars to all-time high, reaching $11.18 By Investing.com - Investing.com Australia
KVAC stock soars to all-time high, reaching $11.18 - Investing.com
Keen Vision Acquisition Corp. SEC 10-K Report - TradingView
Keen Vision Acquisition Co. (NASDAQ:KVAC) Short Interest Update - MarketBeat
BridgeBio's cancer spinout backs SPAC as path to Nasdaq - Fierce Biotech
Keen Vision Acquisition Corp. extends business combination period By Investing.com - Investing.com South Africa
Keen Vision Acquisition Corp. extends business combination period - Investing.com
KVAC stock soars to all-time high of $11.15 amid market optimism - Investing.com Canada
KVAC stock soars to all-time high of $11.15 amid market optimism By Investing.com - Investing.com South Africa
Wolverine Asset Management LLC Has $6.84 Million Stock Holdings in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
KVAC stock soars to all-time high of $11.12 amid market optimism - Investing.com Nigeria
KVAC stock soars to all-time high of $11.12 amid market optimism By Investing.com - Investing.com South Africa
Form 425 Medera Inc. Filed by: Medera Inc. - StreetInsider
0.31%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):